Island Pharmaceuticals advances Marburg study towards December dosing | Stockhead

Island Pharmaceuticals (ASX:ILA) USAMRIID starts surgical preparations for 22 non-human primates ahead of Galidesivir dose optimisation study.

Continue in Briflio to read, react, comment, and share.